Lydia Wakulowsky
Borden Ladner Gervais LLP
Articles
Health Canada’s modernized clinical trial framework: Implications for stakeholders
Canada - June 28 2021 As one of the five key pillars of the Government of Canada's Regulatory Innovation Agenda for health products, Health Canada recently released its…
Product advertising and marketing in the time of COVID-19
Canada - May 8 2020 The COVID-19 pandemic has created unprecedented demand for certain health products, most notably personal protective equipment, diagnostic tests and…
3D printing during COVID-19
Canada - April 6 2020 COVID-19 has led to extraordinary demand for medical equipment and supplies. Global supply chain interruptions means the need for certain medical…
Spotlight on medical devices in the age of COVID-19
Canada - April 2 2020 The global pandemic has created a need for medical devices including diagnostic tests, personal protective equipment, and ventilators. While these…
All Eyes on Hospitals: Mandatory Drug and Medical Device Adverse Event Reporting
Canada - June 27 2019 Traditionally, Health Canada has only required drug and medical device manufacturers to report serious adverse drug reactions and adverse events…
